Identifying poor symptom control in Parkinson's disease.
The range of drugs available to treat people with Parkinson's disease has never been greater. However, patients still encounter difficulties in non-specialist settings where there is often confusion over drug selection, dosage and the timing of dosages. Small adjustments to the type of drug used, dosage and timing can have a significant impact on the control of Parkinson's disease and with it the quality of life of patients, carers and their families. This article provides a brief overview of Parkinson's disease including how to identify poor symptom control.
Scott
Liz
L
Buckinghamshire Hospitals NHS Trust.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001526:Behavioral Symptoms / Q000209:etiology / Q000451:nursing; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D018476:Hypokinesia / Q000188:drug therapy / Q000209:etiology / Q000451:nursing; D007980:Levodopa / Q000627:therapeutic use; D009127:Muscle Rigidity / Q000188:drug therapy / Q000209:etiology / Q000451:nursing; D009730:Nursing Assessment / Q000379:methods; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy* / Q000451:nursing*; D016896:Treatment Outcome; D014202:Tremor / Q000188:drug therapy / Q000209:etiology / Q000451:nursing
D000978:Antiparkinson Agents; D018680:Cholinergic Antagonists; D018491:Dopamine Agonists; D007980:Levodopa